💨 Abstract

The FDA named Dr. George Tidmarsh, a former pharmaceutical executive, as the new director of its drug program. Tidmarsh will oversee the approval and safety monitoring of all U.S. drugs, replacing the acting director who retired last month. This appointment comes amidst a wave of leadership changes and massive layoffs at the FDA, totaling over 3,000 staffers through buyouts, retirements, and dismissals.

Courtesy: WTOP Staff